Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/170029
Title: Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell lines
Author: Olivan Riera, Mireia
Rigau, M.
Colás, E.
Garcia, M.
Montes, M.
Sequeiro, T.
Regis, L.
Celma, A.
Planas, J.
Reventós Puigjaner, Jaume
Torres, I. de
Doll, A.
Morote, J.
Keywords: Aspirina
Càncer de pròstata
Tractament adjuvant del càncer
Aspirin
Prostate cancer
Adjuvant treatment of cancer
Issue Date: 2015
Publisher: Hindawi
Abstract: Nowadays prostate cancer is the most common solid tumor in men from industrialized countries and the second leading cause of death. At the ages when PCa is usually diagnosed, mortality related to cardiovascular morbidity is high; therefore, men at risk for PCa frequently receive chronic lipid-lowering and antiplatelet treatment. The aim of this study was to analyze how chronic treatment with statins, aspirin, and their combination influenced the risk of PCa detection. The tumorigenic properties of these treatments were evaluated by proliferation, colony formation, invasion, and migration assays using different PCa cell lines, in order to assess how these treatments act at molecular level. The results showed that a combination of statins and aspirin enhances the effect of individual treatments and seems to reduce the risk of PCa detection (OR: 0.616 (95% CI: 0.467-0.812), ). However, if treatments are maintained, aspirin (OR: 1.835 (95% CI: 1.068-3.155), ) or the combination of both drugs (OR: 3.059 (95% CI: 1.894-4.939), ) represents an increased risk of HGPCa. As observed at clinical level, these beneficial effects in vitro are enhanced when both treatments are administered simultaneously, suggesting that chronic, concomitant treatment with statins and aspirin has a protective effect on PCa incidence.
Note: Reproducció del document publicat a: https://doi.org/10.1155/2015/762178
It is part of: BioMed Research International, 2015, vol. 2015, p. 762178
URI: http://hdl.handle.net/2445/170029
Related resource: https://doi.org/10.1155/2015/762178
ISSN: 2314-6133
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
700405.pdf2.77 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons